Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 8 min ago
Peer-reviewedLicence not statedMolecular Therapy

An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model

  • Mattia Fumagalli
  • Dongjie An
  • Luca Simula
  • Camille Combe
  • Lisa Aziez
  • Yannick Simoni
  • Marie-Clotilde Alves-Guerra
  • Andrea Valentini
  • Maude Marchais
  • Anaïs Vermare
  • Josquin Moraly
  • Simona Manni
6 more authors
  • Maria Cecilia Quadraccia
  • Concetta Quintarelli
  • Biagio de Angelis
  • Nadège Bercovici
  • Emmanuel Donnadieu
  • Frédéric Pendino
Open at sourceDOICite

Related

  1. CRISPRa screen unveils noncanonical NF-κB to boost the antitumor activity of TCR-based CAR-T cells
    Hanyang Yu, Yingxin Wu, Yue Liu +5
    Cellular and Molecular ImmunologyPeer-reviewedLicence not statedFull textOncologyPMC
  2. CRISPR-Cas9 screen identifies eIF4G2 as a regulator of CD8+ T cell dysfunction
    Erin A Holcomb, Long Jiang, Ashley N Pearson +18
    The Journal of Immunology Author ChoicePeer-reviewedPublisher termsFull textOncologyPMC
  3. 321 Genome-scale CRISPR KO screen identifies PCBP2 as a tumor-intrinsic regulator of cancer cell sensitivity to human CD4+ T cell killing
    Paul Chapman, Iñaki Etxeberría, Benjamin Izar +19
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  4. In Vivo CRISPR Screen Identifies RPS19 as an Immunotherapy Target in Hepatocellular Carcinoma
    Lei He, Duo Yu, Fei Xie +18
    Advanced SciencePeer-reviewedCC BY 4.0Full textOncologyPMCEurope PMC
  5. Tarloxotinib targets tumor hypoxia to improve therapeutic efficacy of immune checkpoint inhibition in a MyD88-dependent manner.
    Zhe Fu, Victoria Jackson-Patel, Kathryn Farrand +7
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textOncologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{fumagalli2026vivo,
  title = {{An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model}},
  author = {Mattia Fumagalli and Dongjie An and Luca Simula and Camille Combe and Lisa Aziez and Yannick Simoni and Marie-Clotilde Alves-Guerra and Andrea Valentini and Maude Marchais and Anaïs Vermare and Josquin Moraly and Simona Manni and Maria Cecilia Quadraccia and Concetta Quintarelli and Biagio de Angelis and Nadège Bercovici and Emmanuel Donnadieu and Frédéric Pendino},
  journal = {Molecular Therapy},
  year = {2026},
  month = nov,
  doi = {10.1016/j.ymthe.2026.04.009},
  url = {https://hal.science/hal-05852551v1},
}
RIS
TY  - JOUR
TI  - An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model
AU  - Mattia Fumagalli
AU  - Dongjie An
AU  - Luca Simula
AU  - Camille Combe
AU  - Lisa Aziez
AU  - Yannick Simoni
AU  - Marie-Clotilde Alves-Guerra
AU  - Andrea Valentini
AU  - Maude Marchais
AU  - Anaïs Vermare
AU  - Josquin Moraly
AU  - Simona Manni
AU  - Maria Cecilia Quadraccia
AU  - Concetta Quintarelli
AU  - Biagio de Angelis
AU  - Nadège Bercovici
AU  - Emmanuel Donnadieu
AU  - Frédéric Pendino
PY  - 2026
DA  - 2026/11/04
JO  - Molecular Therapy
DO  - 10.1016/j.ymthe.2026.04.009
UR  - https://hal.science/hal-05852551v1
SN  - 1525-0016
SN  - 1525-0024
ER  -